JESSICA WHITLOCK: Open Payments
NPI 1295107506 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,418 in 30 payments from 11 companies in 2025. Trend: 2023 $819 · 2024 $1,518 · 2025 $1,418
Food & beverage: $1,418
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $295 |
| AstraZeneca Pharmaceuticals LP | 3 | $246 |
| Corcept Therapeutics | 2 | $207 |
| GlaxoSmithKline, LLC. | 5 | $181 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| GENZYME CORPORATION | 2 | $110 |
| Boston Scientific Corporation | 1 | $87 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $86 |
| ABBVIE INC. | 2 | $44 |
| Novo Nordisk Inc | 1 | $20 |
Products named: BREZTRI, Korlym, MOUNJARO, AREXVY, Auvelity, DUPIXENT, WATCHMAN Access System, QULIPTA.
Industry payments across MO — which companies pay providers there.
